enclomiphene and retatrutide Understanding Enclomiphene: Benefits Usage in Fitness 🚨 The Future of Weight

Tirzepatide is a dual agonist, meaning it activates two hormone pathways: glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1

Tirzepatide came off the FDAs official drug shortage list in December 2024, and semaglutide followed in February 2025, eliminating the legal pathway that allowed compounding pharmacies to produce copies of the drugs

,

The case for daily dosing Daily dosing provides the most consistent blood levels

Antibodies used (Table 1) were titrated and the separation index was calculated using FlowJo version 10 software for every study

Only 10-15% rests in telogen, waiting to shed and make room for new growth